IPX066 245 (Rytary carbidopa 61.25 mg / levodopa 245 mg)

Generic Name: carbidopa/levodopa

Pill imprint IPX066 245 has been identified as Rytary carbidopa 61.25 mg / levodopa 245 mg.

Rytary is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Rytary carbidopa 61.25 mg / levodopa 245 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rytary

Generic Name:

carbidopa/levodopa

Imprint:

IPX066 245

Strength:

carbidopa 61.25 mg / levodopa 245 mg

Color:

Blue

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Impax Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.